Journal of Clinical Oncology, Vol 17, Issue 7
(July), 1999: 2256
© 1999 American Society for Clinical Oncology
Psychosocial Predictors of Survival in Metastatic Melanoma
Phyllis N. Butow,
Alan S. Coates,
Stewart M. Dunn
From the Medical Psychology Unit and Department of Cancer Medicine, University of Sydney, Sydney, and Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, Australia.
Address reprint requests to Phyllis Butow, PhD, Medical Psychology Unit, Royal Prince Alfred Hospital, Camperdown NSW 2050, Australia; email medpsych{at}mail.usyd.edu.au
PURPOSE: Research interest in psychosocial predictors of the onset and course of cancer has been active since the 1950s. However, results have been contradictory and the literature is noted for methodologic weaknesses. In this prospective study, we aimed to systematically obtain data on psychosocial factors associated with human response to illness.
PATIENTS AND METHODS: One hundred twenty-five patients with metastatic melanoma completed questionnaires measuring cognitive appraisal of threat, coping, psychologic adjustment, perceived aim of treatment, social support, and quality of life (QOL). Questionnaires were completed, where possible, every 3 months for 2 years after diagnosis. Survival was measured from date of study entry to date of death or was censored at the date of last follow-up for surviving patients.
RESULTS: In a multivariate Cox regression analysis of baseline data, which controlled for demographic and disease predictors, the psychologic variables of perceived aim of treatment (P < .001), minimization (P < .05), and anger (P < .05) were independently predictive of survival. Patients who were married (P < .01) and who reported a better QOL (P < .05) also survived longer.
CONCLUSION: The prognostic significance of psychologic and QOL scores remained after allowance for conventional prognostic factors. If these associations reflect an early perception by the patient or doctor of disease progression, then measures are at least valuable early indicators of such progression. If psychologic processes have a more direct influence on the course of the underlying illness, then it may be possible to manipulate them for therapeutic effect. We are now conducting a randomized controlled trial of a psychologic intervention to further elucidate these issues.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. H. Boesen, S. H. Boesen, K. Frederiksen, L. Ross, K. Dahlstrom, G. Schmidt, J. Naested, C. Krag, and C. Johansen
Survival After a Psychoeducational Intervention for Patients With Cutaneous Malignant Melanoma: A Replication Study
J. Clin. Oncol.,
December 20, 2007;
25(36):
5698 - 5703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Ying Guo, C. LeDay-Jacobs, J. L. Palmer, and E. Bruera
Psychosocial Assessment of Patients Who Have Undergone Inpatient Cancer Rehabilitation
American Journal of Hospice and Palliative Medicine,
June 1, 2007;
24(3):
196 - 201.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Eton, D. L. Fairclough, D. Cella, S. E. Yount, P. Bonomi, and D. H. Johnson
Early Change in Patient-Reported Health During Lung Cancer Chemotherapy Predicts Clinical Outcomes Beyond Those Predicted by Baseline Report: Results From Eastern Cooperative Oncology Group Study 5592
J. Clin. Oncol.,
April 15, 2003;
21(8):
1536 - 1543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.F. Roychowdhury, A. Hayden, and A.M. Liepa
Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer
J. Clin. Oncol.,
February 15, 2003;
21(4):
673 - 678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Petticrew, R. Bell, and D. Hunter
Influence of psychological coping on survival and recurrence in people with cancer: systematic review
BMJ,
November 9, 2002;
325(7372):
1066 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. George
Research Design in End-of-Life Research: State of Science
Gerontologist,
October 1, 2002;
42(90003):
86 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Samur and P. Butow
Prognosis of Metastatic Melanoma: Where Are the Details?
J. Clin. Oncol.,
December 1, 1999;
17(12):
3856 - 3860.
[Full Text]
[PDF]
|
 |
|
|